This proposed research seeks to examine the behavioral and neural substrates of intranasal oxytocin compared to placebo on alcohol cue-induced alcohol and cigarette craving smokers with an alcohol use disorder (AUD). Non treatment-seeking smokers with an AUD will be recruited to participate in a between-subjects, placebo-controlled, randomized pilot functional magnetic resonance imaging (fMRI) study. Participants will undergo an fMRI scan in conjunction with an alcohol-olfactory cue-reactivity task. Secondary assessments will include alcohol and cigarette craving, alcohol and cigarette consumption, physiological measures (heart rate and blood pressure) and mood measures.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
19
Participants administer the oxytocin (40 IU) twice a day for 5 - 7 days
Participants administer the placebo (40 IU) twice a day for 5 - 7 days
Center for Alcohol and Addiction Studies
Providence, Rhode Island, United States
Alcohol craving
average alcohol craving during the cue-reactivity task
Time frame: 1 day
Cigarette craving
average cigarette craving during the cue-reactivity task
Time frame: 1 day
Brain activity
BOLD response when comparing alcohol to neutral cues during fMRI
Time frame: 1 day
Alcohol and cigarette consumption
alcohol and cigarette consumption assessed by the Timeline Followback
Time frame: 5-7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.